engineering molecular on- and off-switches for controlling car t-cells
Published 5 months ago • 73 plays • Length 1:01Download video MP4
Download video MP3
Similar videos
-
1:02
the use of car-t cell products in a real-world setting
-
1:07
optimizing car-t therapy: regulating car t-cells in vivo
-
1:35
key mechanisms of resistance to car t-cell therapy
-
4:24
investigating production failure and out-of-specification production of car t-cell therapeutics
-
1:55
visualizing car t-cells at work
-
0:51
developing universal car-t therapies for t-all
-
1:39
the role of myeloid cells in car-t cell therapy
-
0:50
improving car-t cell efficacy: optimizing car constructs and counteracting tumor escape
-
1:53
the detection and management of mnts following bcma-directed car-t therapy
-
2:43
manufacturing of car t-cells: new approaches
-
3:33
car t-cells for all
-
1:14
components of the car-hematotox model which allow for prediction of icaht following car-t
-
1:04
the major hurdles and emerging opportunities of car t-cell therapy
-
0:46
scaling up car-t manufacturing with automation and digitalization
-
2:02
advances in off-the-shelf car t-cells
-
1:38
challenges of car-t therapy in the real-world setting
-
5:43
strategies to overcome the current obstacles in car-t manufacturing
-
1:13
car-t nursing education
-
1:06
novel third-generation tlr2 co-stimulatory car-t cells for b-cell malignancies